A clinical formulation indicated for Cholesterol. This medication supports cardiovascular wellness by limiting the production of low-density lipoproteins within the liver.
A statin medication indicated to manage high cholesterol and developed to alleviate cardiovascular risks by supporting healthy lipid levels.
Mechanism of Action
It inhibits the HMG-CoA reductase enzyme in the liver. This reduces cholesterol production and increases the removal of LDL (bad) cholesterol from the blood.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Active liver disease, Pregnancy, Breastfeeding, Use of cyclosporine
Severe Adverse Events
Rhabdomyolysis, Liver failure, Severe allergic reaction, Increased blood sugar
Information for Livalo is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
